Φορτώνει......
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
Biologics have changed expectation and outcomes for rheumatoid arthritis (RA). However, the optimal duration and sequence of therapy for this disease has yet to be determined. Also, a significant number of patients do not satisfactorily respond to currently available therapies. The Janus kinase (JAK...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Musculoskelet Dis |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315227/ https://ncbi.nlm.nih.gov/pubmed/28255337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X16687481 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|